Superworth

Bluejay Diagnostics EPS BJDX

Diluted earnings per share by quarter and over the last twelve months, from 2020.

Last 12 months, to Jun 30, 2026
−$34.72
Latest quarter, Q2 FY26
−$4.48
Fiscal year 2025
−$98.84

Bluejay Diagnostics' earnings per share was −$34.72 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$4.48.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$98.84n/a
FY2024−$11689.44n/a
FY2023−$58776.00n/a
FY2022−$59008.00n/a
FY2021−$52480.00n/a
FY2020n/an/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$4.48n/a−$34.72
Q1 FY26−$7.80n/a−$52.80
Q4 FY25−$6.28n/a−$98.84
Q3 FY25−$16.16n/a−$136.24
Q2 FY25−$22.56n/a−$1351.12
Q1 FY25−$53.84n/a−$5427.12
Q4 FY24−$43.68n/a−$11689.44
Q3 FY24−$1231.04n/a−$23549.76
Q2 FY24−$4098.56n/a−$35654.72
Q1 FY24−$6316.16n/a−$49156.16
Q4 FY23−$11904.00n/a−$58776.00
Q3 FY23−$13336.00n/a−$61976.00

Against its peers

Companies in Medical - Instruments & Supplies nearest Bluejay Diagnostics' size, closest first, today.

CompanyEPS, 12 months
BJDXBluejay Diagnostics−$34.72
VJETFlyte Aviationn/m
PFSAProfusan/m
IVFINVO Fertilityn/m
BBLGBone Biologics−$1.41
TNONTenon Medical−$25.65
AMIXAutonomix Medicaln/m
NXGLNexgel−$14.20
ADGMAdagio Medical−$1.43
GCTKGlucotrackn/m
XAIRBeyond Air−$68.40
Peer median−$14.20

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Bluejay Diagnostics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.